Your shopping cart is currently empty

4-TCPA is a potent inhibitor of VEGFR2. It induces apoptosis and causes cell cycle arrest, potentially by inhibiting VEGFR2 and EGFR signaling, while also affecting the mTOR pathway. Furthermore, 4-TCPA suppresses the viability and proliferation of various cancer cell lines. It is applicable in research on cancers such as lung cancer, breast cancer, and leukemia.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | 4-TCPA is a potent inhibitor of VEGFR2. It induces apoptosis and causes cell cycle arrest, potentially by inhibiting VEGFR2 and EGFR signaling, while also affecting the mTOR pathway. Furthermore, 4-TCPA suppresses the viability and proliferation of various cancer cell lines. It is applicable in research on cancers such as lung cancer, breast cancer, and leukemia. |
| In vitro | 4-TCPA exhibits varying IC50 values across different cell lines when tested for 72 hours, with an IC50 of 35.70 μM in A549 cells, 19.50 μM in MCF7 cells, 5.95 μM in K562 cells, and 135.2 μM in HFF2 cells. Within the 5.95-35.70 μM range over 72 hours, 4-TCPA induces apoptosis by activating the mitochondrial pathway in the K562, MCF7, and A549 cell lines, demonstrating different levels of sensitivity. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.